tapebrief
Key financials Q4 FY2026 Metric Q4 FY2026 YoY Q3 FY2026 QoQ Revenue $2.22B +7.0% $1.95B +13.6% EPS $3.82 — $2.72 +40.4% Operating margin 24.6% — 18.4% +620bps
Guidance Broadridge raised FY2027 EPS growth guidance to 8-12% and closed sales to $290-330M, signaling confidence in deal conversion despite guiding recurring revenue growth slightly lower at 6-8%.
Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.
Actuals vs prior guidance Metric Period Prior guide Actual Δ Result Adjusted EPS growth FY 2026 10-12% 9.6 non-GAAP EPS (FY2026 actual) In-line with prior guidance range midpointMet Recurring revenue growth (constant currency) FY 2026 At or above 7% 8% (Q4 FY2026 reported; full-year embedded in reported results) Above the 7% minimum guidanceMet Adjusted Operating income margin FY 2026 20-21% 26.9% (Q4 FY2026 reported) +5.9-6.9 points above guidance rangeBeat Closed sales FY 2026 $240-290M $158M (Q4 FY2026 reported) -$82-$132M below guidance rangeBeat
New guidance Metric Period Guide YoY Adjusted EPS growth FY 2027 8-12% — Recurring revenue growth (constant currency) FY 2027 6-8% — Adjusted Operating income margin FY 2027 ~21% — Free cash flow conversion FY 2027 100%+ — Closed sales FY 2027 $290-330 million —
Segment KPIs Q4 FY2026 Segment Q4 FY2026 YoY Investor Communication Solutions $1.732B +8.0% Global Technology and Operations $0.488B +5.0%
Other KPIs Q4 FY2026 Segment Q4 FY2026 Recurring revenues $1,542 million Recurring revenue growth (constant currency) 8% Closed sales $158 million Adjusted Operating income margin 26.9% Equity revenue position growth 14% Mutual fund/ETF position growth 7% Internal Trade Growth 15% Free cash flow conversion 110%
Answers to last quarter's watch list What to watch into next quarter Get the next brief, free. We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.